共 32 条
[1]
Deane K.H., Flaherty H., Daley D.J., Pascoe R., Penhale B., Clarke C.E., Et al., Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease, BMJ Open, 4, 12, (2014)
[2]
Krishnan S., Sarma G., Sarma S., Kishore A., Do nonmotor symptoms in Parkinson's disease differ from normal aging?, Mov Disord, 26, 11, pp. 2110-2113, (2011)
[3]
Hinnell C., Hurt C.S., Landau S., Brown R.G., Samuel M., Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?, Mov Disord, 27, 2, pp. 236-241, (2012)
[4]
Kwok J.Y.Y., Auyeung M., Hyl C., Examining Factors Related to Health-Related Quality of Life in People with Parkinson's Disease, Rehabil Nurs, (2018)
[5]
Chaudhuri K.R., Healy D.G., Schapira A.H., National Institute for clinical E. non-motor symptoms of Parkinson's disease: Diagnosis and management, Lancet Neurol, 5, 3, pp. 235-245, (2006)
[6]
Seppi K., Ray Chaudhuri K., Coelho M., Fox S.H., Katzenschlager R., Perez Lloret S., Et al., Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review, Mov Disord, 34, 2, pp. 180-198, (2019)
[7]
Connolly B., Fox S.H., Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease, Neurotherapeutics., 11, 1, pp. 78-91, (2014)
[8]
UK Parkinson's Audit - Transforming Care, (2017)
[9]
Pfeiffer R.F., Management of Autonomic Dysfunction in Parkinson's disease, Semin Neurol, 37, 2, pp. 176-185, (2017)
[10]
Weintraub D., Morales K.H., Moberg P.J., Bilker W.B., Balderston C., Duda J.E., Et al., Antidepressant studies in Parkinson's disease: A review and meta-analysis, Mov Disord, 20, 9, pp. 1161-1169, (2005)